Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
05:37
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

52nd ERA-EDTA Congress

 

28-31 May 2015 London
FAQs
   
Discussion forum - 52nd ERA-EDTA Congress
    Topic - J4) Chronic Kidney Disease. Anaemia.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 424
Visits: 38
Title: ERYPTOSIS INDUCED BY INDOXYL SULFATE IS RELATED TO OXIDATIVE STRESS.
Authors: Andrea N Moreno-Amaral ,
Centre: Pontifícia Universidade Católica do Paraná

You must be registered to reply or comment.

ERYPTOSIS INDUCED BY INDOXYL SULFATE IS RELATED TO OXIDATIVE STRESS.

Andrea N Moreno-Amaral
Thread initiator
Subspeciality
Reg: 5/14/2015 8:35:00 PM
Comment# 1
Uremic toxins may play a critical role in chronic kidney disease (CKD)-related anemia (Lang et al., 2012) by inducing eryptosis thorough mechanisms not fully understood. Renal anemia is involved in the pathogenesis of increased oxidative stress in CKD patients (Klahr, 1997; Vaziri, 2004), due its association with the overproduction of reactive oxygen species (ROS) and reduction of antioxidant defenses (Dobashi et al., 2000). N-acetyl-L-cysteine (NAC) is a cysteine donor with antioxidant properties and diphenyleneiodonium (DIP) is an inhibitor of NADPH oxidase. The present study explored the potential of the uremic toxin indoxyl sulfate (IS) in promoting eryptosis and ROS production and the effect of NAC or DIP treatment.

Comment added on 5/14/2015 8:35:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 625
Visits: 3858
Title: IS 4 CITRATE AN EFFECTIVE TOOL AS A CATHETER LOCKING SOLUTION?
Authors: Joao Fazendeiro Matos ,
Centre: Fresenius Medical Care | NephroCare Portugal

Poster most viewed in this topic
Poster: 380
Visits: 225
Title: JTZ-951, AN ORAL NOVEL HIF-PHD INHIBITOR, ELEVATES HEMOGLOBIN IN JAPANESE ANEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
Authors: Tadao Akizawa ,
Centre: Showa University School of Medicine, Division of Nephrology, Department of Medicine


 






PosterSessionOnline
Logo Draft
 
Logo Cert